Drawing for SYNKLINO

USPTO serial 79371712

SYNKLINO

Reviewed by CopyMark Law Group

Reg. 7410895Status 700Registered
Filing date
Status date
Registration date
Jun 11, 2024
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SYNKLINO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Howard W. Kline

Howard W. Kline Nath, Goldberg & Meyer112 S. West StreetAlexandria, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention of chronic viral infections in high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for regulating the immune system for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for use in organ transplantation for elimination of chronic viral infections; pharmaceutical preparations for the prevention of diseases of the immune system; immunosuppressants for use following transplantation to prevent graft rejection; pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunotherapeutic agents for treatment of bacterial infections; pharmaceutical preparations for immunity adjustment for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations containing stem cells for high-risk immunocompromised patients and transplant recipients; immunoassay reagents for medical use; pharmaceutical preparations for the treatment of viral diseases; anti-viral agents; protein synthesis inhibitors for high-risk immunocompromised patients and transplant recipients; regulatory proteins being pharmaceutical preparations for medical use for high-risk immunocompromised patients and transplant recipients; pharmaceutical drugs for high-risk immunocompromised patients and transplant recipients; antibacterial pharmaceuticalsACTIVE—
010Surgical apparatus and instruments for medical use; medical diagnostic test instruments for use in immunoanalytical procedures; medical diagnostic testing apparatus for use in medical immunoassay procedures; medical devices for regenerating stem cells for medical purposes; medical apparatus for cell sampling; pharmaceutical instruments and apparatus provided empty used for the inhalation of pharmaceuticalsACTIVE—
042Scientific research; scientific laboratory services; scientific research into stem cells; culturing of cells for scientific research purposes; scientific and medical research services for research and development in the field of immunology; pharmaceutical research; development of pharmaceutical preparations; pharmaceutical research and development services; development of pharmaceutical preparations and medications; carrying out clinical trials for pharmaceutical products; laboratory research on pharmaceutical preparations; consultancy in the field of drug research and development; software as a service (SAAS) services featuring software for gathering, tracking, analyzing and activating data in relation to transformative therapies for high-risk immunocompromised patients and transplant recipientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 14, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 22, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 22, 2024FIMPFINAL DISPOSITION PROCESSED—
Sep 11, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 11, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 11, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 26, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 20, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 19, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 19, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 19, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2023RFNTREFUSAL PROCESSED BY IB—
Oct 24, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 24, 2023RFRRREFUSAL PROCESSED BY MPU—
Oct 14, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 13, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2023DOCKASSIGNED TO EXAMINER—
Jun 16, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 8, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance